剖宫产子宫切除术中预防性髂内动脉球囊置入治疗胎盘植入谱系疾病
单中心回顾性队列研究纳入2018年10月至2020年11月连续30例病理确诊胎盘植入谱系疾病并计划分娩的单胎活产孕妇,比较预防性髂内动脉球囊置入(T1期10例)与未置入(T2期20例)的结局。球囊置入未减少估计失血量、红细胞输注或手术并发症,但麻醉时间、手术室时间和手术时间均增加。
要点
- 预防性髂内动脉球囊置入未减少估计失血量、红细胞输注或手术并发症。
- 球囊置入与麻醉时间、手术室时间和手术时间增加相关。
- 两组术后住院时间相似,球囊置入中位耗时74分钟(范围46-109分钟)。
核心结论
- 预防性髂内动脉球囊置入与估计失血量减少、红细胞输注减少或手术并发症减少无关。
- 球囊置入与麻醉时间、手术室时间和手术时间增加相关。
研究设计与样本
- 单中心回顾性队列研究,纳入2018年10月至2020年11月连续30例病理确诊胎盘植入谱系疾病并计划分娩的单胎活产孕妇。
- T1期(2018年10月至2019年8月)10例在手术开始前于手术室置入预防性髂内动脉球囊导管,新生儿娩出后充盈球囊,子宫切除完成后放气。
- T2期(2019年9月至2020年11月)20例未使用血管内导管。
- 两个时期所有手术均由专门的多学科团队采用标准化手术方法完成。
- 比较采用Wilcoxon秩和检验和Fisher精确检验。
主要发现
- 两组手术病理诊断为植入性或穿透性胎盘植入的患者比例均为80%。
- 中位估计失血量T1期为875 mL,T2期为1000 mL(P=.84)。
- 需要任何浓缩红细胞输注的比例T1期为60%,T2期为40%(P=.44);需要>4单位浓缩红细胞的比例T1期为20%,T2期为5%(P=.25)。
- 每组各有1例患者发生手术并发症。
- 中位麻醉时间T1期为497分钟,T2期为296分钟(P<.001);中位手术室时间T1期为498分钟,T2期为205分钟(P<.001);中位手术时间T1期为227分钟,T2期为182分钟(P<.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The utility of prophylactic endovascular internal iliac balloon placement in the surgical management of placenta accreta spectrum is debated. OBJECTIVE: In this study, we review outcomes of surgical management of placenta accreta spectrum with and without prophylactic endovascular internal iliac balloon catheter use at a single institution. STUDY DESIGN: This is a retrospective cohort study of consecutive viable singleton pregnancies with a confirmed pathologic diagnosis of placenta accreta spectrum undergoing scheduled delivery from October 2018 through November 2020. In the T1 period (October 2018-August 2019), prophylactic endovascular internal iliac balloon catheters were placed in the operating room before the start of surgery. Balloons were inflated after neonatal delivery and deflated after hysterectomy completion. In the T2 period (September 2019-November 2020), endovascular catheters were not used. In both time periods, all surgeries were performed by a dedicated multidisciplinary team using a standardized surgical approach. The outcomes compared included the estimated blood loss, anesthesia duration, operating room time, surgical duration, and a composite of surgical complications. Comparisons were made using the Wilcoxon rank-sum test and the Fisher exact test. RESULTS: A total of 30 patients were included in the study (T1=10; T2=20). The proportion of patients with placenta increta or percreta was 80% in both groups, as defined by surgical pathology. The median estimated blood loss was 875 mL in T1 and 1000 mL in T2 (P=.84). The proportion of patients requiring any packed red blood cell transfusion was 60% in T1 and 40% in T2 (P=.44). The proportion of patients requiring >4 units of packed red blood cells was 20% in T1 and 5% in T2 (P=.25). Surgical complications were observed in 1 patient in each group. Median operative anesthesia duration was 497 minutes in T1 and 296 minutes in T2 (P<.001). Median duration of operating room time was 498 minutes in T1 and 205 minutes in T2 (P<.001). Median surgical duration was 227 minutes in T1 and 182 minutes in T2 (P<.05). The median duration of time for prophylactic balloon catheter placement was 74 minutes (range, 46-109 minutes). The median postoperative length of stay was similar in both groups (6 days in T1 and 5.5 days in T2; P=.36). CONCLUSION: The use of prophylactic endovascular internal iliac balloon catheters was not associated with decreased blood loss, packed red blood cell transfusion, or surgical complications. Catheter use was associated with increased duration of anesthesia, operating room time, and surgical time.
引用
- Overton E, Booker WA, Mourad M, et al. Prophylactic endovascular internal iliac balloon placement during cesarean hysterectomy for placenta accreta spectrum. Am J Obstet Gynecol MFM. 2022. PMID: 35597402. doi:10.1016/j.ajogmf.2022.100657
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。